-
admin
Posts
Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024
Biologics License Application currently under review by U.S. FDA; PDUFA goal date of December 28, 2024 WALTHAM, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) — Checkpoint...
BrainsWay Announces Significant Expansion on U.S. East Coast
14 Deep TMS™ Devices Ordered by Large Mental Health Network BURLINGTON, Mass. and JERUSALEM, Sept. 16, 2024 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE:...
Psyence Biomed Issues Shareholder Update Recapping Recent Progress and Previewing Key Upcoming Data Milestones
Initiated Phase IIb study of nature-derived psilocybin as a potential treatment for Adjustment Disorder in Palliative Care Expanded pipeline into Alcohol Use Disorder...
Angitia Biopharmaceuticals to Present Data on AGA2118 for Osteoporosis at ASBMR 2024
Abstracts selected for 2 oral presentations and 2 poster presentations, including clinical and preclinical data sets WOODLAND HILLS, Calif., Sept. 16, 2024 (GLOBE NEWSWIRE) —...
Abata Therapeutics Appoints Joanne Beck, Ph.D., as Chief Technical Officer
Dr. Beck’s extensive experience in CMC and product development will be instrumental as Abata enters clinical development this year WATERTOWN, Mass., Sept. 16, 2024 (GLOBE...
Vazyme Leads Life Science Innovation, Boosting Research Breakthroughs in mIDH1 Cancer Treatment
NANJING, China, Sept. 16, 2024 /PRNewswire/ — Vazyme (688105.SH), a leading life science technology company, significantly contributed to groundbreaking research published in Science Magazine through...
PhytoHealth Corporation announced a new clinical study results published at 2024 ESMO Congress: PG2 plus preoperative chemoradiotherapy improves survival in patients with locally advanced esophageal cancer
TAIPEI and BARCELONA, Spain, Sept. 16, 2024 /PRNewswire/ — A groundbreaking study conducted by PhytoHealth Corporation, a leading provider of botanical medicine, has revealed that combining...
China Automotive Systems Announces Annual Meeting on September 24, 2024
CAAS announces the conference call and webcast information for the Annual Meeting of Stockholders to be held on Tuesday, September 24, 2024 at 9:00 AM...
Antennova Releases Latest Data of CD73 Inhibitor ATN-037, including a DCR of 89.5%, in a Mini Oral at ESMO Congress 2024
In patients with non-small cell lung cancer (NSCLC) or melanoma who had acquired resistance to checkpoint inhibitors (CPIs), ATN-037 in combination with KEYTRUDA®(pembrolizumab) demonstrated an...
Halal Route Application – Eat, Travel around Thailand, Safe and Sound Halal Style
BANGKOK, Sept. 16, 2024 /PRNewswire/ — The Halal Science Center, Chulalongkorn University has developed Halal Route, an application that lists restaurants, lodging, mosques, prayer directions, and...